Law Articles

Return to Law Dictionary Index

Remeron Settlement Results in $36 Million for Consumers

Source: PR Newswire
Published: April 04, 2005

Thousands of consumers nationwide who purchased the antidepressant drug Remeron or its generic equivalent, mirtazapine, may get cash back based on their out-of-pocket expenses.

The cash recovery is a result of a $36 million nationwide settlement with drug maker Organon USA Inc. and its parent company Akzo Nobel N.V. for allegedly improperly monopolizing the U.S. market for the drugs. The settlement is subject to approval.

The lawsuit alleged that Organon unlawfully extended its monopoly by improperly listing a new "combination therapy" patent with the U.S. Food and Drug Administration. In addition, the complaint alleged that Organon delayed listing the patent with the FDA in another effort to delay the availability of lower-cost generic substitutes, resulting in higher prices to those who paid for the drug.

Consumers and third-party payors wanting claim forms and more information about the settlement may call toll-free at 1-866-401-6807 or visit the settlement website at http://www.remeronsettlement.com/.
Read Full Story at PR Newswire

Return to Health Law

Return to Law Dictionary Index